222 related articles for article (PubMed ID: 34463905)
1. Prevalence and Impact of Treatment-Resistant Depression in Latin America: a Prospective, Observational Study.
Soares B; Kanevsky G; Teng CT; Pérez-Esparza R; Bonetto GG; Lacerda ALT; Uribe ES; Cordoba R; Lupo C; Samora AM; Cabrera P
Psychiatr Q; 2021 Dec; 92(4):1797-1815. PubMed ID: 34463905
[TBL] [Abstract][Full Text] [Related]
2. Suicidality and Quality of Life in Treatment-Resistant Depression Patients in Latin America: Secondary Interim Analysis of the TRAL Study.
Corral R; Alessandria H; Agudelo Baena LM; Ferro E; Duque X; Quarantini L; Caldieraro MA; Cabrera P; Kanevsky G
Front Psychiatry; 2022; 13():812938. PubMed ID: 35308889
[TBL] [Abstract][Full Text] [Related]
3. [Major depressive disorder and treatment-resistant depression: an epidemiological analysis in Argentina of the Study of Treatment-Resistant Depression in Latin America].
García Bonetto G; Corral RM; Lupo C; Vilapriño Duprat M; Alessandria H; Kanevsky G; Cabrera P
Vertex; 2022 Mar; XXXIII(155):36-49. PubMed ID: 35438684
[TBL] [Abstract][Full Text] [Related]
4. Association of Treatment-Resistant Depression With Patient Outcomes and Health Care Resource Utilization in a Population-Wide Study.
Lundberg J; Cars T; Lööv SÅ; Söderling J; Sundström J; Tiihonen J; Leval A; Gannedahl A; Björkholm C; Själin M; Hellner C
JAMA Psychiatry; 2023 Feb; 80(2):167-175. PubMed ID: 36515938
[TBL] [Abstract][Full Text] [Related]
5. The prevalence and economic burden of treatment-resistant depression in Thailand.
Prasartpornsirichoke J; Pityaratstian N; Poolvoralaks C; Sirinimnualkul N; Ormtavesub T; Hiranwattana N; Phonsit S; Rungnirundorn T
BMC Public Health; 2023 Aug; 23(1):1541. PubMed ID: 37573321
[TBL] [Abstract][Full Text] [Related]
6. Comorbidity and healthcare utilization in patients with treatment resistant depression: A large-scale retrospective cohort analysis using electronic health records.
Adekkanattu P; Olfson M; Susser LC; Patra B; Vekaria V; Coombes BJ; Lepow L; Fennessy B; Charney A; Ryu E; Miller KD; Pan L; Yangchen T; Talati A; Wickramaratne P; Weissman M; Mann J; Biernacka JM; Pathak J
J Affect Disord; 2023 Mar; 324():102-113. PubMed ID: 36529406
[TBL] [Abstract][Full Text] [Related]
7. Burden of treatment-resistant depression in Medicare: A retrospective claims database analysis.
Pilon D; Joshi K; Sheehan JJ; Zichlin ML; Zuckerman P; Lefebvre P; Greenberg PE
PLoS One; 2019; 14(10):e0223255. PubMed ID: 31600244
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of treatment resistant depression among major depressive disorder patients in Israel.
Sharman Moser S; Chodick G; Gelerstein S; Barit Ben David N; Shalev V; Stein-Reisner O
BMC Psychiatry; 2022 Aug; 22(1):541. PubMed ID: 35948895
[TBL] [Abstract][Full Text] [Related]
9. Economic burden of treatment-resistant depression among veterans in the United States.
Szukis H; Joshi K; Huang A; Amos TB; Wang L; Benson CJ
Curr Med Res Opin; 2021 Aug; 37(8):1393-1401. PubMed ID: 33879005
[TBL] [Abstract][Full Text] [Related]
10. Economic impact of treatment-resistant depression: A retrospective observational study.
Pérez-Sola V; Roca M; Alonso J; Gabilondo A; Hernando T; Sicras-Mainar A; Sicras-Navarro A; Herrera B; Vieta E
J Affect Disord; 2021 Dec; 295():578-586. PubMed ID: 34509073
[TBL] [Abstract][Full Text] [Related]
11. A retrospective chart review study to quantify the monthly medical resource use and costs of treating patients with treatment resistant depression in the United Kingdom.
Denee T; Ming T; Waller J; Bailey T; Rajkovic-Hooley O; Middleton-Dalby C; Le HH; Zhang Q; McCrone P; Taylor D
Curr Med Res Opin; 2021 Feb; 37(2):311-319. PubMed ID: 33253055
[TBL] [Abstract][Full Text] [Related]
12. An Evaluation of the Clinical and Economic Burden Among Older Adult Medicare-Covered Beneficiaries With Treatment-Resistant Depression.
Benson C; Szukis H; Sheehan JJ; Alphs L; Yuce H
Am J Geriatr Psychiatry; 2020 Mar; 28(3):350-362. PubMed ID: 31735488
[TBL] [Abstract][Full Text] [Related]
13. Burden of Treatment Resistant Depression (TRD) in patients with major depressive disorder in Ontario using Institute for Clinical Evaluative Sciences (ICES) databases: Economic burden and healthcare resource utilization.
McIntyre RS; Millson B; Power GS
J Affect Disord; 2020 Dec; 277():30-38. PubMed ID: 32791390
[TBL] [Abstract][Full Text] [Related]
14. Depression and suicidality severity among TRD patients after 1-year under standard of care: Findings from the TRAL study, a multicenter, multinational, observational study in Latin America.
Caldieraro MA; Tung TC; Agudelo Baena LM; Vilapriño Duprat M; Corral RM; Alviso de la Serna LD; Saucedo E; Kanevsky G; Cabrera P
Span J Psychiatry Ment Health; 2023; 16(2):85-94. PubMed ID: 38591721
[TBL] [Abstract][Full Text] [Related]
15. Current treatments used in clinical practice for major depressive disorder and treatment resistant depression in England: A retrospective database study.
Denee T; Kerr C; Ming T; Wood R; Tritton T; Middleton-Dalby C; Massey O; Desai M
J Psychiatr Res; 2021 Jul; 139():172-178. PubMed ID: 34077893
[TBL] [Abstract][Full Text] [Related]
16. Health-related quality of life burden associated with treatment-resistant depression in UK patients: Quantitative results from a mixed-methods non-interventional study.
Rathod S; Denee T; Eva J; Kerr C; Jacobsen N; Desai M; Baldock L; Young AH
J Affect Disord; 2022 Mar; 300():551-562. PubMed ID: 34965398
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Pre-existing Conditions Relevant for Adverse Events and Potential Drug-Drug Interactions Associated with Augmentation Therapies Among Patients with Treatment-Resistant Depression.
Zhdanava M; Karkare S; Pilon D; Joshi K; Rossi C; Morrison L; Sheehan J; Lefebvre P; Lopena O; Citrome L
Adv Ther; 2021 Sep; 38(9):4900-4916. PubMed ID: 34368919
[TBL] [Abstract][Full Text] [Related]
18. Use of home health and other healthcare delivery pathways among privately insured patients with and without treatment-resistant depression.
Pilon D; Szukis H; Singer D; Morrison L; Sheehan JJ; Lefebvre P
Curr Med Res Opin; 2020 May; 36(5):865-874. PubMed ID: 31985319
[No Abstract] [Full Text] [Related]
19. Direct and Indirect Cost Burden and Change of Employment Status in Treatment-Resistant Depression: A Matched-Cohort Study Using a US Commercial Claims Database.
Amos TB; Tandon N; Lefebvre P; Pilon D; Kamstra RL; Pivneva I; Greenberg PE
J Clin Psychiatry; 2018; 79(2):. PubMed ID: 29474009
[TBL] [Abstract][Full Text] [Related]
20. Descriptive analysis of the economic burden of treatment resistance in a major depressive episode.
Cai Q; Sheehan JJ; Wu B; Alphs L; Connolly N; Benson C
Curr Med Res Opin; 2020 Feb; 36(2):329-335. PubMed ID: 31540559
[No Abstract] [Full Text] [Related]
[Next] [New Search]
